C_(16)H_(14)SNF分子中不共面共轭环上π轨道通过键的相互作用的研究

本文根据我们测定的C_(16)H_(14)SNF(1)和C_(16)H_(16)SNF(2)晶体结构数据,用MNDO2方法进行分子轨道研究,发现1和2的几何构型虽然相近,但其分子轨道中的原子轨道组成有着质的差异:在HOMO和临近HOMO的占据分子轨道中,2的两个苯环的π轨道彼此没有相互作用;1的两个夹角为80°的苯环的π轨道同时出现在一个分子轨道中,彼此通过(?)C=N—键导通,显示出相互作用,与实验观察到的核磁共振谱一致.     

呋喃与HCl和CHCl3构成的分子间氢键的理论研究

量子化学从头算方法MP2研究了呋喃-HCl体系和呋喃-CHCl₃体系的分子间氢键的本质. 主要研究了这两个体系中新的氢键类型C(Cl)—H…O和C(Cl)—H…π的相互作用. 研究表明, 氯仿与呋喃分子之间的相互作用使氯仿中C—H键长缩短, 振动频率增大(蓝移), 而HCl与呋喃分子之间的相互作用使H—Cl键长增长, 振动频率减小(红移). 利用自然键轨道(NBO)分析表明电荷从质子受体转移到C—H反键轨道和Cl原子的孤对电子轨道上.     

烷基取代对罗丹明的电子结构与光谱的影响

在密度泛函理论(DFT)的B3LYP水平对不同烷基在不同位置取代形成的8种罗丹明化合物进行结构优化,并在此基础上应用含时密度泛函理论(TD-DFT)和单激发组态相互作用(CIS)方法分析了取代基对罗丹明的电子结构、前线分子轨道及电子光谱的影响.计算结果表明,前线分子轨道主要分布在罗丹明分子的氧杂蒽环上,罗丹明分子中两个N端的H各只有1个H被烷基取代时,最高占据轨道(HOMO)在主要共轭环分布最多,且HOMO和最低未占据轨道(LUMO)分布比例相差最小,两个N端4个H同时被甲基取代时,能隙最窄,对气相最大吸收波长红移程度最大,两个N端4个H同时被乙基取代时,气相荧光最大,发射波长最长.     

瓜环与含羟基功能基二胺包结配合物的晶体结构及相互作用的研究

合成并表征了含羟基功能基的二胺1,3-二(2-氨基苯氧基)-2-丙醇(客体). 利用X射线衍射方法研究了客体与八元瓜环Q[8]所形成包结配合物的晶体结构. 结果表明主客体间形成了1∶2的包结配合物, 两个客体分子分别从瓜环的两个端口进入瓜环内腔, 在腔内两个客体分子中的苯环间存在着π-π相互作用. 利用1H NMR技术及紫外-可见吸收光谱对主客体间的相互作用进行考察, 所得结果与晶体结构吻合.     

OCS,CO2,N2O与烯、炔烃之间π…π作用的电子密度拓扑研究

采用MP2/aug-cc-pVDZ方法对氧硫化碳(OCS)、二氧化碳(CO2)、一氧化二氮(N2O)与乙烯(C2H4)、乙炔(C2H2)、2-丁炔(C4H6)之间形成的平行构型复合物中的分子间相互作用进行了理论研究.复合物的相互作用能按照B…C2H4B…C2H2>B…C4H6(B=OCS,CO2,N2O)的顺序依次减小.采用电子密度拓扑分析理论方法,讨论了复合物中π…π作用的成键特性.电子密度拓扑分析表明复合物中形成了弱的分子间相互作用,且以静电作用为主;π电子密度分子图与全电子密度分子图中键径方向是一致的,说明π…π作用在本文所讨论的体系中起着很重要的作用.NBO分析表明净电荷迁移从电子给体C2H4,C2H2,C4H6到电子受体OCS,CO2,N2O,迁移数按照B…C2H4相似文献   

新型[1+1]Schiff碱大环化合物的合成与表征

在硫酸催化作用下,采用前体二醛1,7-二(2’-甲酰苯基)-4-氮-1,7-二氧-4-(4’-对甲苯磺酸基)庚烷(1)和1,7-二(2’-甲酰苯基)-1,4,7三氧庚烷(2)与二胺化合物N,N’-(2-胺基苯基)-2,6-二甲酰亚胺吡啶(3)分别进行缩合,得到[1+1]Schiff碱大环化合物4和5,并用元素分析、1H NMR、IR和质谱等对大环化合物4和5进行表征.同时用X射线衍射方法测定了2个前体和2个Schiff碱大环的晶体结构.单晶X射线衍射结果表明,2个大环化合物分子中,分子内氢键作用导致整个分子呈现为一扭曲"8"字形构型,分子内一对苯环之间的π-π相互作用进一步稳定其分子的扭曲结构.其紫外研究结果显示,大环化合物4和5对镧(III)离子具有选择性识别作用.     

（HAINH）n（n=2—3）环状化合物的结构特征

用自洽场理论（HF）和密度泛函理论（DFT）的B3LYP方法，在6－3G的水平上对化合物（HAlNH)2和（HAlNH)3的几何结构进行优化，并分别与环丁二烯C4H4和苯分子C6H6的结构和成键方式进行比较。以B3LYP／STO－3G方法讨论其分子轨道波函数．。结果表明：C4H4和（HAlNH)2均为D2h对称，前者为长方形结构，形成两个孤立的π键，而后者为菱形结构，形成一个π4^4键。C6H6和（HAlNH)3分子点群分别为D6h和D3h，并均形成一个π6^6键，成键原子对分子轨道的贡献不同，其中C原子是完全等价的。而Al和N原子各不相同，N原子比Al的贡献要大得多。     

2，2′—双吡啶双氯二价铂化合物Pt（bpy）Cl2（黄色）的电子结构和电子光谱性质的从头计算研究

用从头算MP2方法,采用LANL2DZ基组,对Pt(bpy)Cl2分子进行了分子轨道计算,计算得到这种分子的HOMO和LUMO都具有反键π^*轨道的性质,给出了具有较高能量的分子轨道的顺序,并分析了各分子轨道的组成,用单激发组态相互作用（CIS）方法计算了具有“单体”晶型的Pt(bpy)Cl2的电子吸收光谱的发射光谱,结果表明：最低能吸收光谱为γ＝350．99nm,具有金属到配体的电荷迁移性质;最低能发射光谱为γ＝566．39nm,具有配体内电荷迁移的性质。     

4-[2-(4,6-二甲氧基-2-嘧啶氧基)苄胺基]苯甲酸正丙酯的合成和晶体结构

2-甲砜基-4,6二甲氧基嘧啶和N-(4-丙氧羰基苯基)-2-羟基苄胺在四氢呋喃溶液中反应, 生成标题化合物4-[2-(4,6-二甲氧基-2-嘧啶氧基)苄胺基]苯甲酸正丙酯,并测定了其晶体结构。该化合物分子式为C23H25N3O5,晶体属单斜晶系,空间群为P2/n,晶胞参数为a = 14.8504(8),b = 9.4420(4),c = 16.3129(9) 牛 = 104.881(1)埃琕 = 2210.6(2) 3,Z = 4,Dc = 1.272 g/cm3,F(000) = 896.00,(MoK? = 0.91 cm-1,R = 0.051,wR = 0.118,获得19761衍射数据,其中独立衍射点5004个。经元素分析、IR、MS和HNMR等对化合物的结构进行了表征。在分子结构中,各有3个不同的共轭平面。嘧啶环和苯环(C(7) C(12)),及苯环(C(14) C(19))的夹角分别为99.18 , 164.15埃?个苯环之间的夹角为94.93啊;衔锍世啻焦瓜蟆?     

(HAlNH)n(n=2～3)环状化合物的结构特征

用自洽场理论 (HF)和密度泛函理论 (DFT)的B3LYP方法 ,在 6 31G 的水平上对化合物(HAlNH) 2 和 (HAlNH) 3 的几何结构进行优化 ,并分别与环丁二烯C4 H4 和苯分子C6H6的结构和成键方式进行比较。以B3LYP STO 3G方法讨论其分子轨道波函数 (Ψ)。结果表明 :C4 H4 和 (HAlNH) 2 均为D2h对称 ,前者为长方形结构 ,形成两个孤立的π键 ;而后者为菱形结构 ,形成一个π44键。C6H6和 (HAlNH) 3分子点群分别为D6h和D3h,并均形成一个π66键。成键原子对分子轨道的贡献不同 ,其中C原子是完全等价的 ,而Al和N原子各不相同 ,N原子比Al的贡献要大得多     

2-甲基-1,5-苯并硫氮杂的基态和激发态反应的研究 I: 2-甲基-1,5-苯并硫氮杂-4(5H)-酮的卤化和亲核取代反应

2-甲基-1,5-苯并硫氮杂-4(5H)-酮(1a)与不同的氯化试剂-五氯化磷、三氯氧磷和氯化砜在不同的条件下氯化,可分别生成:2-甲基-4-氯-1,5-苯并硫氮杂(2a)、2-氯-4-甲基-1,5-苯并硫氮杂(3a)、2-二氯甲基苯并噻唑(5)、2-三氯甲基苯并噻唑(6)和2-甲基-1,5-苯并硫氮杂-4(5H)-酮盐酸盐(4).2-甲基-4-氯-1,5-苯并硫氮杂与醇钠反应生成相应的2-甲基-4-烷氧基-1,5-苯并硫氮杂外,还可以分离到它的2,4-异构体,2-烷氧基-4-甲基-1,5-苯并硫氮杂.产物的结构均经元素分析、红外光谱、^1H和^1^3C核磁共振谱和质谱鉴定.     

2-甲基-1,5-苯并硫氮杂的基态和激发态反应的研究III:2-甲基-1,5-苯并硫氮杂4-(5H)-酮与-4-甲基-1,5-苯并硫氮杂-2(3H)-酮间的互变异构

用化学反应和光谱分析证实了2-甲基(1,5)苯并硫氮杂环庚三烯-4(5H)-酮和4-甲基(1,5)苯并硫氮杂环庚三烯-2(3H)-酮是作为互变异构混合物存在的.     

Determination of midazolam and its major hydroxy metabolite in plasma by gas liquid chromatography. Application to a pharmacokinetic study

A sensitive gas liquid chromatographic (GLC) assay was developed for plasma determinations of 8-chloro-6-(2′ -fluorophenyl)-1-methyl-4H-imidazo[1,5 α][1,4]benzodiazepine (compound I) and its hydroxymethylimidazo metabolite (compound II). The internal standards used were 8-chloro-6-(2′ -chlorophenyl)-1 -methyl-4H-imidazo[1,5 α][1,4]benzodiazepine (compound VI) and 7-chloro-5-(2′ -fluorophenyl)-1, 3-dihydro-1-(hydroxyethyl)-2H-1,4-benzodiazepin-2-one (compound VII) for compounds I and II, respectively. Following extraction, and silylation for compound II, compounds I and II were analyzed by GLC using a glass column packed with 5% OV-101 on Gas-Chrom Q, and a ⁶³Ni electron-capture detector. The GLC method was validated by a CI-GC/MS technique. The detection limit of the assay is approximately 4–5 ng/ml for compound I and 3 ng/ml for compound II. The method was used in comparative pharmacokinetic studies of the distribution of the two compounds in arterial and venous blood.     

A promising class of luminescent derivatives of Silver(I) and Gold(I)-N-heterocyclic carbene

Starting from proligand 1-methyl-2-(phenyl)imidazo[1,5-a]pyridine-2-iumchloride ( 1 .HCl), 1-methyl-2-(phenyl)imidazo[1,5-a]pyridine silver(I)chloride, ( 2 ) has been prepared. Synthesis, structures and photophysical properties of (2,2^/−bipyridyl)-1-methyl-2-(phenyl)imidazo[1,5-a]pyridinesilver(I)hexaflurophosphate, ( 3 ), 1-methyl-2-(phenyl)imidazo[1,5-a]pyridinesilver(I)carbazolate, ( 4 ) and 1-methyl-2-(phenyl)imidazo[1,5-a]pyridinegold(I)carbazolate, ( 5 ) are focused. Herein we have first reported the NHC-Ag-(bpy/carbazole). All the complexes have been characterized by elemental analysis, various spectroscopic studies and finally screened for luminescent properties. All the complexes are strongly emissive. Solid state structures of 2 , 3 , 4 and 5 have been determined by X-ray diffraction studies. Conventionally, complex 2 adopts linear geometry whereas complex 3 embraces triangular planar geometry around Ag; complex 4 and 5 clinches linear geometry around Ag/Au. All the complexes absorb light within 275–343 nm. Complex 3 is luminous at ~407 mn, whereas complex 4 and 5 luminous at ~360 nm having short life time 1.00–6.97 ns. The quantum yield (Φ_em) of the complexes varies 0.106–0.186. It is expected variation of luminescence arises due to change of metal and the chromophore (bpy/carbazole). Density Functional Theory (DFT) and Temparature Dependent Density Functional Theory (TDDFT) calculations were performed to verify crystallographically derived parameters and to calculate the UV–Vis properties of the ground state as well as of the first excited state of the complexes.     

二氮双环阳离子游离基中N,N'-三电子键

用从头算HF/3-21+G^*优化了二氮双环[m,n,l]游离基阳离子(m,n,l≥2～5)。分子[4,4,4]和[2,2,2]^+.,[3,3,3]^+.,[4,4,4]^+.游离基阳离子的优势构型有D3对称性,而其它游离基阳离子的优势构型为非对称性。通过比较这些阳离子几何构型,HOMO和NHOMO(即NextHOMO和HOMO-1),和由MNDO计算确定的原子对作用能,表明当二氮双环游离基阳离子的桥链(CH2)n的n≥3时,桥头氮原子通过空间相互用用形成了一个弱的N,N'-三电子σ键。形成的三电子键强度不随环的扩大而增强。而三电子键强度被两个因素影响：一个是桥头氮原子间的p轨道重叠的取向;另一个是它们相应p轨道成分。     

An ab initio molecular orbital study of structures and energies of spirocompounds: spiro[3.3]heptane and spiro[3.3]hepta-1,5-diene

Ab initio molecular orbital theory with the STO-3G and 4-31G basis sets is used to determine the equilibrium geometries, enthalpies of formation, strain energies and spiro-interactions for spiro[3.3]heptane and spiro[3.3]hepta -1,5 - diene. For spiro[3.3]heptane, molecular mechanics calculations suggest that the component cyclobutane rings are puckered to a greater extent than in cyclobutane itself. For spiro[3.3]hepta - 1,5 - diene, STO-3G calculations predict that the component cyclobutene rings deviate slightly from an orthogonal arrangement. Spiro-interactions in spiro[3.3]hepta - 1,5 - diene are revealed by comparing the calculated structural parameters and strain energies with those of appropriate reference systems. The π-orbitals in spiro[3.3]hepta -1,5 -diene are predicted to be split by about 0.4 eV.     

Structural modulation of Cu(I) and Cu(II) complexes of sterically hindered tripyridine ligands by the bridgehead alkyl groups

Structures of Cu(I) and Cu(II) complexes of sterically hindered tripyridine ligands RL = tris(6-methyl-2-pyridyl)methane (HL), 1,1,1-tris(6-methyl-2-pyridyl)ethane (MeL), and 1,1,1-tris(6-methyl-2-pyridyl)propane (EtL), [Cu(RL)(MeCN)]PF(6) (1-3), [Cu(RL)(SO(4))] (4-6), and [Cu(RL)(NO(3))(2)] (7-9), have been explored in the solid state and in solution to gain some insights into modulation of the copper coordination structures by bridgehead alkyl groups (CH, CMe, and CEt). The crystal structures of 1-9 show that RL binds a copper ion in a tridentate facial-capping mode, except for 3, where EtL chelates in a bidentate mode with two pyridyl nitrogen atoms. To avoid the steric repulsion between the bridgehead alkyl group and the 3-H(py) atoms, the pyridine rings in Cu(I) and Cu(II) complexes of MeL and EtL shift toward the Cu side as compared to those in Cu(I) and Cu(II) complexes of HL, leading to the significant differences in the nonbonding interatomic distances, H.H (between the 3-H(py) atoms), N.N (between the N(py) atoms), and C.C (between the 6-Me carbon atoms), the Cu-N(py), Cu-N(MeCN), and Cu-O bond distances, and the tilt of the pyridine rings. The copper coordination geometries in 4-6, where a SO(4) ligand chelates in a bidentate mode, are varied from a square pyramid of 4 to distorted trigonal bipyramids of 5 and 6. Such structural differences are not observed for 7-9, where two NO(3) ligands coordinate in a monodentate mode. The structures of 1-9 in solution are investigated by means of the electronic, (1)H NMR, and ESR spectroscopy. The (1)H NMR spectra show that the structures of 1-3 in the solid state are kept in solution with rapid coordination exchange of the pyridine rings. The electronic and the ESR spectra reveal the structural changes of 5 and 6 in solution. The bridgehead alkyl groups and 6-Me groups in the sterically hindered tripyridine ligand play important roles in modulating the copper coordination structures.     

Molecular and crystal structures of N,N′-propylene- and N,N′-phenylene-diylbis [3-(1-aminoethyl)-6-methyl-2H-pyran-2,4(3H)-dione]

Two macrocyclic ligands, N,N′-propylene-diylbis[3-(1-aminoethyl)-6-methyl-2H-pyran-2,4(3H)-dione] I and N,N′-phenylene-diylbis[3-(1-aminoethyl)-6-methyl-2H-pyran-2,4(3H)-dione] II, have been prepared by the condensation of dehydroacetic acid (3-acetyl-4-hydroxy-6-methyl-2H-pyran-2-one) with 1,2-phenylenediamine and 1,3-propylenediamine. They have been characterized by means of elemental analysis, IR spectroscopy as well as by X-ray crystallography. The molecular structures of the compounds I and II can be described as consisting of two β-enaminone-2-pyrone rings interlaced with either alkyl chain in I or phenyl ring in II. The X-ray studies confirmed the existence of strong N–HO intramolecular hydrogen bonds in both structures. Their lengths are in accordance to lengths of RAHB intramolecular hydrogen bonds in 1,3-diketones, aryl-hydrazones, β-enaminones and related heterodienes (2.5–2.6 Å) [P. Gilli, V. Bertolasi, V. Ferretti and G. Gilli, J. Am. Chem. Soc., 122 (2000) 10405].     

Coordination Compounds of Cobalt(II), Nickel(II), and Copper(II) Halides with 2-Methyl-1,2,4-Triazolo[1,5-a]benzimidazole

Russian Journal of Coordination Chemistry - New coordination compounds of Co(II), Ni(II), and Cu(II) halides with 2-methyl-1,2,4-triazolo[1,5-a]benzimidazole (L), [Co(L)2Cl2] (Ia),...     

Synthesis of pyrazolo[4,3-d]oxazoles

1-Phenyl-3-methyl-5-pyrazolone-4-oxime reacted with benzylamine, methylamine, methyl- and ethyl ioides to give 3-methyl-1,5-diphenyl-1H-, 3-methyl-1-phenyl-1H- and 3,5-dimethyl-1-phenyl-1H-pyrazolo[4,3-d]oxazoles I, II. The structure of I was elucidated authentically through other routes by interaction of 1-phenyl-3-methyl-4,5-dioxopyrazolone with benzylamine and/or benzaldehyde and ammonium acetate. Various 3-meth-yl-5-aryl-1-phenyl-1H-pyrazolo[4,3-d]oxazoles IV were synthesized by the reaction of 4,5-dioxopyrazolone with aromatic aldehydes in the presence of ammonium acetate. Also, the structure of I was elucidated authentically via other routes by the reaction of 1-phenyl-3-methyl-4-imino-5-pyrazolone with each of benzylcyanide, benzylamine, benzaldehyde and benzalaniline.